Paola Lattus

HEMOSONICS AWARDED FDA 510(k) CLEARANCE FOR QUANTRA® HEMOSTASIS SYSTEM WITH QSTAT® CARTRIDGE

Retrieved on: 
Wednesday, November 30, 2022
Barts Health NHS Trust, Patient, Trauma, Public health, Food, Headquarters, R, PBM, Royal London, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, System, Thrombosis, Paola Lattus, Senior lecturer, Trust, SEER, Blood, Hemostasis, High-dependency unit, St Bartholomew's Hospital, FDA, Medical imaging, Medical device, Hospital

DURHAM, N.C., Nov. 30, 2022 /PRNewswire/ -- HemoSonics, LLC, a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced today that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the Quantra Hemostasis System with QStat Cartridge.

Key Points: 
  • "The Quantra Hemostasis System with QStat Cartridge is breaking new ground and leading innovation in the point-of-care and laboratory-based whole blood hemostasis testing market.
  • The FDA clearance of the QStat Cartridge expands the Quantra System's indications for use to include trauma, and liver transplantation procedures.
  • "The Quantra Hemostasis System with QStat and QPlus Cartridges will assist more clinicians in determining which specific blood products are needed to rapidly treat individual patients.
  • HemoSonics is part of the Stago group, a leading company in thein vitrodiagnostics industry dedicated to exploring thrombosis and hemostasis.

Egg Medical Receives CE Mark for EggNest™ Radiation Protection System Release

Retrieved on: 
Wednesday, November 30, 2022
Hypertension, Anatomy, Wilson, Multimedia, Risk, X-ray, Angioplasty, Radiology, Physician, Workflow, Radiation, CE marking, Paola Lattus, Carbon, Cancer, CE, Cataract, Electrophysiology, Cardiac catheterization, Medical imaging

ARDEN HILLS, Minn., Nov. 30, 2022 /PRNewswire/ -- Egg Medical, Inc ., a medical device company commercializing technologies to reduce scatter radiation exposure during interventional angiographic procedures, today announced that it has achieved CE Mark for the EggNest XR radiation protection system.

Key Points: 
  • ARDEN HILLS, Minn., Nov. 30, 2022 /PRNewswire/ -- Egg Medical, Inc ., a medical device company commercializing technologies to reduce scatter radiation exposure during interventional angiographic procedures, today announced that it has achieved CE Mark for the EggNest XR radiation protection system.
  • With the CE Mark certification, Egg Medical will continue expansion into all markets recognizing the CE Mark.
  • "With CE mark approval of the EggNest platform, we are bringing this protection to more interventional teams worldwide."
  • The EggNest XR is a comprehensive, scatter radiation protection system fully integrated into the workflow of the modernCath Lab.

Canon Medical Components U.S.A., Inc. Announces Launch of New Products in the U.S., to be on Display at RSNA 2022

Retrieved on: 
Tuesday, November 29, 2022
CXDI, Deep learning, Radiological Society of North America, Diagnosis, Environment, Communication, IP55, Anatomy, Radio, AI, Multimedia, RSNA, Life, App Store (iOS/iPadOS), Patient, Education, Workflow, Paola Lattus, Noise, X-ray, Radiology, AEC, Canon Inc., Dust, Intelligence, NR, Abdomen, Medical device, Medical imaging, 3D printing, Typesetting, Canon

RSNA 2022 is a global radiology forum where the power of imaging, education and collaboration come to life.

Key Points: 
  • RSNA 2022 is a global radiology forum where the power of imaging, education and collaboration come to life.
  • Canon Medical Components U.S.A., Inc. is displaying a number of innovative products, some that are now available for the first time in the United States.
  • The Canon CXDI-Pro wireless digital radiography systems are designed to support the demands of medical imaging departments for cost-effective solutions without compromise.
  • As of July 1, 2020, the digital radiography components business of Canon U S.A., Inc. has been transferred to Canon Medical Components U.S.A., Inc. Visit https://mcu.canon.

Avail Medsystems to Participate in the Jefferies Virtual Private MedTech Summit

Retrieved on: 
Tuesday, November 29, 2022
Machine learning, Paola Lattus, Silicon, Health, Medtech, Organization, AI, Hospital, Medical device

SANTA CLARA, Calif., Nov. 29, 2022 /PRNewswire/ -- Avail, the digital hub of the operating room enabling the medical technology (MedTech) and healthcare industries to connect regardless of location andwork smarter to advance patient care, today announced that Daniel Hawkins, Chief Executive Officer of Avail, will participate in a fireside chat at the Jefferies Virtual Private MedTech Summit on Tuesday, December 6, 2022 at 10:30 a.m.

Key Points: 
  • SANTA CLARA, Calif., Nov. 29, 2022 /PRNewswire/ -- Avail, the digital hub of the operating room enabling the medical technology (MedTech) and healthcare industries to connect regardless of location andwork smarter to advance patient care, today announced that Daniel Hawkins, Chief Executive Officer of Avail, will participate in a fireside chat at the Jefferies Virtual Private MedTech Summit on Tuesday, December 6, 2022 at 10:30 a.m.
  • Avail enables the MedTech industry and healthcare providers to work together more often and more efficiently, harnessing expertise and technology in and out of the OR to accelerate the innovation, adoption, and reach of tools and techniques to improve patient care.
  • Today, 50 MedTech organizations have contracted with Avail to rethink commercial models, reduce inefficiencies, and enhance the reach and timeliness of collaboration.
  • Avail was founded in 2017 by MedTech veterans with a vision to leverage Silicon Valley technology expertise to evolve the industry and enable MedTech and healthcare to deliver the best care possible.

Couchbase on AWS Enables Arthrex to Improve Patient Outcomes With IoT Data Collected at the Edge

Retrieved on: 
Monday, November 28, 2022
Software, Internet, Environment, Elective surgery, Communication, Organization, Engineering, Multimedia, Hospital, Health, Patient, Capella, Database, IOT, Amazon Web Services, GDPR, Paola Lattus, Linux, AWS, Percussion section, Transport Layer Security, Surgeon, Ecosystem, JSON, Name, Research, HIPAA, Medical imaging, Medical device, Online shopping, NoSQL, Couchbase Server

LAS VEGAS, Nov. 28, 2022 /PRNewswire/ -- Couchbase, Inc. (NASDAQ: BASE), the cloud database platform company, today announced that Arthrex, a global leader in minimally invasive surgical technology, selected Couchbase on Amazon Web Services (AWS) to improve patient outcomes. Embedded in the Arthrex Synergy product family, Couchbase is used in customer hospitals and operating rooms to manage the capture, sync and storage of patient data, surgical data and media metadata, including captured images and videos from Arthrex devices. This data powers Synergy SurgeonVault, Arthrex's cloud-based surgeon-patient communication tool, enabling surgeons to quickly create post-operative reports for ongoing patient care.

Key Points: 
  • This data powers Synergy SurgeonVault, Arthrex's cloud-based surgeon-patient communication tool, enabling surgeons to quickly create post-operative reports for ongoing patient care.
  • "At Arthrex, we are dedicated to helping surgeons tap into technology to provide advanced treatment for patients and improve outcomes.
  • That's why hospitals rely on SurgeonVault to empower surgeons with access to patient data whenever they need it," said Gregory St. Clair, software architect at Arthrex.
  • Couchbase is then used to sync data from edge devices across the hospital network in a reliable and secure manner.

Arthrex, Richard Wolf Announce Partnership to Expand Comprehensive Operative Care Solutions

Retrieved on: 
Monday, November 28, 2022
Urology, Endoscopy, Elective surgery, Arthroplasty, Trauma, Multimedia, Partnership, Patient, Spine, Paola Lattus, Marketing, Surgeon, Synergy, Gynaecology, General surgery, OR, Health insurance, Medical device

NAPLES, Fla., Nov. 28, 2022 /PRNewswire/ -- Arthrex and Richard Wolf, global leaders in minimally invasive surgical technology and solutions, announced a U.S.-based partnership to offer comprehensive technology and product offerings in urology, gynecology and general surgery.

Key Points: 
  • "Arthrex and Richard Wolf are united in their missions to advance health care and improve patient outcomes.
  • Through this partnership, health care professionals in the U.S. will experience a comprehensive and complimentary line of surgical solutions for urology, gynecology and general surgery in a single package," said Arthrex Director of Global Endoscopy Jeremy Roberts.
  • "Richard Wolf is excited to engage in this collaboration in the U.S. with Arthrex," said Jim Fagan, U.S. Corporate Director of Sales and Marketing for Richard Wolf.
  • Richard Wolf is a full-service provider in endoscopy, offering a wide range of instrumentation and system solutions for minimally invasive medicine.

KRONOS ADVANCED TECHNOLOGIES INVITES CUSTOMERS TO SHOP FOR THE MOST POPULAR AIR PURIFIER MODELS OF THE YEAR DURING THE BLACK FRIDAY EVENT OF 2022. SOME OF THE BEST DISCOUNTS OFFERED ON THE MOST POPULAR PRODUCTS.

Retrieved on: 
Tuesday, November 22, 2022
Social media, Marketing, Allergen, Purification, MSRP, Breese-Wilde Model 5, OTC, Restaurant, CORE, Healthcare Facilities Accreditation Program, IAQ, Operation Model 5, Smoke, Hospital, Student, Indoor air quality, Bacteria, KNOS, Remington Model 8, Disinfectant, Arm, School, Maintenance, Sale, HEPA, Paola Lattus, CADR, University, Bloomberg Businessweek, Noise, Gas, News, Black Friday, Virus, Public policy, DOGE, AIR, Research, Atmosphere, OTC Markets Group, MODEL, Tesla Model 3, Car, 3D printing, Sewage, Kronos

We also offer a personal air purifier for outdoor activity -FIT AIR that is wearable on your arm.

Key Points: 
  • We also offer a personal air purifier for outdoor activity -FIT AIR that is wearable on your arm.
  • Kronos products for safer indoor air quality include Model 3, Model 5, and Model 8 (also marketed as Airdog products).
  • The Company offers a unique air purifier, Tesla Air, to keep the air in your car the safest.
  • Kronos also supplies advanced US-manufactured face masks (including high-tech electronic invisible masks) to better protect employees, customers, students, and teachers nationwide.

Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference

Retrieved on: 
Tuesday, November 22, 2022
Magnetic resonance imaging, Conference, Paola Lattus, Patient, Fifth, High-dependency unit, MRI, Swoop, Interest, FDA, Medical imaging

GUILFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system, today announced that the company will be participating in the upcoming 5th AnnualEvercore ISI HealthCONx Conference.

Key Points: 
  • GUILFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system, today announced that the company will be participating in the upcoming 5th AnnualEvercore ISI HealthCONx Conference.
  • Hyperfine management is scheduled to present onWednesday, Nov 30, 2022,at9:15 AM Eastern Time.
  • Interested parties may access a live and archived webcast of the presentation on the Investors section of the companys website at: https://investors.hyperfine.io .
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

Clinical Evidence Shows Reduced Costs and Improved Outcomes in Heart Transplantation

Retrieved on: 
Tuesday, November 22, 2022
Biotechnology, General Health, Health, Cardiology, ASAIO, FDA, Hospital, CE, MCS, Multimedia, CTS, Temperature, Research, Society, Paola Lattus, Data, American Society for Artificial Internal Organs, ICE, Patient, Medical device

The study illustrates the favorable post-operative impact that advanced preservation technology may have on hospital costs and patient outcomes after heart transplant procedures.

Key Points: 
  • The study illustrates the favorable post-operative impact that advanced preservation technology may have on hospital costs and patient outcomes after heart transplant procedures.
  • View the full release here: https://www.businesswire.com/news/home/20221122005269/en/
    Paragonix SherpaPak Cardiac Transport System (CTS) has preserved more than 2,200 hearts since start of clinical use in 2018.
  • The leading FDA cleared and CE marked preservation device for heart transportation, Paragonix SherpaPak CTS provides a sterile, temperature and pressure-controlled environment for organs traveling between operating rooms.
  • In this study, the results indicate that the Paragonix SherpaPak can potentially improve the post-transplant outcomes of patients, leading to lowered overall costs for hospitals.

New View Surgical, Inc. Closes $12.1M Series B-1 Financing, Readies Limited Market Release of its VisionPort™ System For Minimally Invasive Surgery

Retrieved on: 
Monday, November 21, 2022
Surgery, Medical Devices, Health, Radiology, Health Technology, Hospital, Surgeon, New View, Series, New York Angels, Paola Lattus, MIS, Growth, Medical device

“The message from surgeons who've used the VisionPort couldn't be clearer -- the device simplifies and enhances operators' view of the surgical field,” said Dr. John Younger, a member of the New View Surgical Board and one of the deal leads for the New York Angels. “Beyond that, I think what drove investors into the deal was this: the instrument's capacity to eliminate the need for a separate team member to manage a conventional laparoscope and VisionPort's capacity to reduce capital and recurring equipment costs makes the value proposition impactfully economic for surgical practices.”

Key Points: 
  • New View Surgical, Inc ., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), today announced the closure of a $12.1M Series B-1 equity financing round to fund the commercialization of its VisionPort System.
  • The company expects to launch the VisionPort System in the US before the end of 2022.
  • In emerging markets, the VisionPort System will greatly reduce the capital-intensive equipment currently required to perform minimally invasive surgery, and thus, make state-of-the-art technology more accessible.
  • New View Surgical is an emerging medical device company focused on the development and commercialization of the VisionPort System, a novel surgical imaging and access system for minimally invasive surgery.